“…Several cellular lipid phosphatases have been identified that will dephosphorylate PtdIns(3,4,5)P 3 to PtdIns(3,4)P 2 in vitro, most of them members of a family of phosphatases that has been termed the inositol polyphosphate 5-phosphatase family. , These include the synaptojanins, , Oculocerebrorenal (Lowe) (OCRL) phosphatase, the type II , and type IV 5-phosphatases, as well as the SH2-containing inositol phosphatase-1 (SHIP1) and SHIP2 . However, thus far evidence is lacking that the synaptojanins, OCRL, the type II, and type IV 5-phosphatases antagonize growth factor-stimulated PI3K signaling, and studies indicate that the principle cellular substrate for some of these phosphatases may be PtdIns(4,5)P 2 rather than PtdIns(3,4,5)P 3 . − , In contrast, there is significant evidence that SHIP1 and SHIP2 function as cellular PtdIns(3,4,5)P 3 phosphatases converting PtdIns(3,4,5)P 3 to another putative second messenger PtdIns(3,4)P 2 .…”